Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial

被引：0
|
作者：
Favi, E. [1 ]
Silvestrini, N. [1 ]
Spagnoletti, G. [1 ]
Castagneto, M. [1 ]
Citterio, F. [1 ]
机构：
[1] Catholic Univ, Rome, Italy
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
388
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [21] Basiliximab induction therapy in pediatric renal transplantation, A double blind clinical trial
    Otukesh, Hasan
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1532 - 1532
  • [22] Abbreviated thymoglobulin and basiliximab induction therapy in patients undergoing kidney transplantation results in superior graft and patient survival with less infectious complications
    Whittaker, Vaughn
    Gruessner, Angelika
    Gruessner, Rainer
    TRANSPLANTATION, 2016, 100 (07) : S379 - S379
  • [23] Thymoglobulin Versus Basiliximab as Induction Treatment in Kidney Transplantation from Donors after Cardiac Death
    Perez-Flores, I.
    Sanchez-Fructuoso, A.
    Florit, E.
    Calvo, N.
    Barrientos, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 252 - 252
  • [24] THE INITIAL RESULTS OF THE DECEASED DONOR KIDNEY TRANSPLANTATION AFTER INDUCTION OF ANTI-THYMOCYTE GLOBULIN (ATG) VERSUS BASILIXIMAB FROM THE NEW KOREAN KIDNEY TRANSPLANTATION CENTER
    Ju, Ik Moon
    Seong, Uk Cheon
    In, Seok Choi
    TRANSPLANT INTERNATIONAL, 2015, 28 : 368 - 368
  • [25] Basiliximab vs Steroids in liver transplantation immunosuppression. A prospective randomized clinical trial.
    Lupo, L
    Ricci, P
    Caputi, L
    Tandoi, F
    Aquilino, F
    Di Palma, G
    Gallerani, A
    Cesana, A
    Stefano, M
    Memeo, V
    LIVER TRANSPLANTATION, 2005, 11 (07) : C75 - C75
  • [26] Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
    Haynes, R.
    Harden, P.
    Landray, M.
    Baigent, C.
    Friend, P.
    TRANSPLANTATION, 2014, 98 : 155 - 155
  • [27] Improved safety of basiliximab (Simulect®) over antithymocyte globulin (Thymoglobulin®) induction therapy in heart transplantation
    Mattei, M. F.
    Boissonnat, P.
    Redonnet, M.
    Gandjbakhch, I.
    Bandini, A. Mouly
    Dorent, R.
    Yan, C.
    Blanc, A. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S62 - S62
  • [28] COST-EFFECTIVENESS OF BASILIXIMAB AS INDUCTION THERAPY FOR KIDNEY TRANSPLANTATION IN MEXICO
    Lemus, A.
    Jimenez Aranda, P.
    VALUE IN HEALTH, 2013, 16 (07) : A699 - A699
  • [29] Induction With Basiliximab Plus Thymoglobulin Is Effective and Safe in Old-for-Old Renal Transplantation: Six-Month Results of a Prospective Clinical Study
    Favi, E.
    Gargiulo, A.
    Spagnoletti, G.
    Salerno, M. P.
    Silvestrini, N.
    Valente, I.
    Citterio, F.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (04) : 1114 - 1117
  • [30] Thymoglobulin Induction Therapy in Deceased Donor Kidney Transplantation: Single-Center Experience in Mexico
    Martinez-Mier, G.
    Soto-Miranda, E.
    Budar-Fernandez, L. F.
    Mateu-Rivera, L. J.
    Gomez-Diaz, A.
    Trujillo-Martinez, M. F.
    Uscanga-Montesano, A.
    Avila y Falfan, D.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (02) : 596 - 599
12345